Shell Asset Management’s Bionano Genomics BNGO Stock Holding History

Shell Asset Management’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20	Closed	-$14K	–	1282
2023 Q1	$14K	Sell	20 -1	-5%	-$888	﹤0.01%	1238
2022 Q4	$18K	Sell	21 -1	-5%	-$1.26K	﹤0.01%	1319
2022 Q3	$24K	Sell	22 -2	-8%	-$2.64K	﹤0.01%	1369
2022 Q2	$20K	Hold	24	–	–	﹤0.01%	1393
2022 Q1	$37K	Sell	24 -4	-14%	-$5.4K	﹤0.01%	1355
2021 Q4	$50K	Hold	28	–	–	﹤0.01%	1371
2021 Q3	$92K	Sell	28 -1	-3%	-$3.5K	﹤0.01%	1312
2021 Q2	$128K	Buy	+29	New	+$114K	﹤0.01%	1323

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Shell Asset Management's BNGO Position: Q2 2023 in Review

Shell Asset Management sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 20 shares — an estimated $14K sold.

Shell Asset Management first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $128K in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

Shell Asset Management reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
Shell Asset Management sold 20 Bionano Genomics shares in Q2 2023, an estimated $14K.
Shell Asset Management first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
Shell Asset Management's Bionano Genomics position peaked at $128K in Q2 2021.
108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Shell Asset Management's 13F filing for Q2 2023, filed 28 Jul 2023.